hypertriglyceridemia
Conditions
Interventions
control group:Placebo
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-70 years; 2. Patients with primary dyslipidemia; 3. 1.7mmol/L<=TG<11.3mmol/L(1000mg/dl) ; 4. Those who have not taken lipid-lowering drugs in the past 1 month; 5. Can adhere to long-term medication; 6. The patient's informed consent and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Recent (within 4 weeks) myocardial infarction, or stenting, or bypass surgery, or stroke; 2. Diabetes mellitus, nephrotic syndrome and renal insufficiency; 3. Hypothyroidism or poor control of other endocrine diseases; 4. Liver function is more than 2 times higher than the upper limit of normal value; 5. Patients with severe or active liver disease; 6. Those who have any other life-threatening or serious illness and cannot complete the 12-week treatment to the extent that it affects the evaluation results; 7. Patients with allergic constitution; 8. Pregnant or planning to become pregnant; 9. Patients with hemolytic anemia and glucose-6-phosphate dehydrogenase deficiency; 10. Other diseases or mental disorders that researchers believe may limit the evaluation of efficacy or follow-up of patients; 11. Patients who have participated in clinical trials of other drugs within the last 4 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Triglyceride; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total cholesterol;Low density lipoprotein cholesterol;High density lipoprotein cholesterol;Fasting blood glucose; | — |
Countries
China
Contacts
Public ContactWu Shengxian
Outcome results
None listed